Understanding IgA Nephropathy: Causes, Symptoms, Diagnosis, and Treatment

IgA nephropathy (Berger's disease) is the most common primary glomerulonephritis worldwide. It occurs when immunoglobulin A (IgA)—an antibody produced by the immune system—accumulates in the kidney's filtering units (glomeruli), triggering inflammation and progressive damage.

Key Points

  • Cause: Aberrant glycosylation of IgA1 leads to immune complex formation and glomerular deposition. Genetic susceptibility (HLA, complement genes) + environmental triggers (infections, mucosal immunity dysregulation).
  • Symptoms: Range from asymptomatic to macroscopic hematuria (cola-colored urine, often post-infection), foamy urine (proteinuria), edema, hypertension, flank pain. Many diagnosed incidentally.
  • Diagnosis: Urinalysis (hematuria, proteinuria), blood tests (creatinine, eGFR, IgA levels), kidney biopsy (gold standard—shows mesangial IgA deposits, MEST-C scoring).
  • Treatment: Focus on slowing progression: blood pressure control (<130/80), RAAS blockade (ACEi/ARB), SGLT2 inhibitors, proteinuria reduction. Immunosuppression (corticosteroids, targeted release budesonide) for high-risk cases. Complement inhibitors emerging. Lifestyle: low sodium, weight management, smoking cessation, avoid NSAIDs.
  • Prognosis: Highly variable. ~30–40% remain stable; 20–40% progress to ESRD over 20 years. Early diagnosis and aggressive risk factor modification improve outcomes.

Living with IgA Nephropathy

  • Regular nephrology follow-up (every 3–6 months typically).
  • Home blood pressure monitoring.
  • Annual influenza, pneumococcal, COVID vaccines (avoid live vaccines if immunosuppressed).
  • Pregnancy counseling: preconception planning essential; ACEi/ARB contraindicated in pregnancy.
  • Support networks: IgAN Foundation, patient communities.

Regular monitoring and early intervention are crucial for managing IgA nephropathy effectively and preserving kidney function long-term.

Kidney Disease - Related Articles